AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team
AUAUniversity30 Apr 2025

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team CME Available: https://auau.auanet.org/node/42822 At the conclusion of this CME activity, participants will be able to: 1. Apply the mechanism of action of PARP inhibitors and the rationale for using them in patients with advanced prostate cancer. 2. Recognize the role and importance of genetic testing in patients with mCRPC and the implications of germline mutations on response to therapy. 3. Identify best practices and utilize available guidelines for patients with mCRPC to optimize treatment success and oncologic outcomes. 4. Recognize when to use PARP inhibitors as monotherapy, the rationale and indications for combination therapy, and appropriate treatment sequencing. 5. Successfully counsel patients on the possible adverse events associated with PARP inhibitor therapies alone or in combination. ACKOWLEDGEMENTS Support provided by independent educational grants from: AstraZeneca Merck & Co., Inc.

Avsnitt(425)

MIBC Treatment Landscape (Republished)

MIBC Treatment Landscape (Republished)

MIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Jen-Jane Liu, MD, FACS CME Available: https://cme.auanet.org/URL/GUPOD252 ACKNOWLEDGEMENTS: Support provided by in...

11 Mars 24min

AUA2025: Key Takeaways: Bladder Cancer

AUA2025: Key Takeaways: Bladder Cancer

AUA2025: Key Takeaways: Bladder Cancer Presenters: Patrick Hensley, MD & Janet Kukreja, MD

4 Mars 23min

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons...

25 Feb 30min

Adjuvant Therapy for Renal Cell Carcinoma

Adjuvant Therapy for Renal Cell Carcinoma

Adjuvant Therapy for Renal Cell Carcinoma Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Daniel Shapiro, MD, FACS CME Available: https://cme.auanet.org/URL/RCCPOD261 ACKNOWLEDGEMENTS: Support provided...

18 Feb 25min

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Karen L. Stern, MD

11 Feb 14min

Update Series:  The Role of Nephrectomy in Advanced Kidney Cancer

Update Series: The Role of Nephrectomy in Advanced Kidney Cancer

Update Series: The Role of Nephrectomy in Advanced Kidney Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Sarah P. Psutka, M.D., M.S., F.A.C.S. Now in its 45th installment, the AUA Update Series...

28 Jan 21min

AI for Prostate Cancer Treatment Planning

AI for Prostate Cancer Treatment Planning

AI for Prostate Cancer Treatment Planning  Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Wayne G. Brisbane, MD

21 Jan 24min

AUA Guidelines: Salvage Therapy for Prostate Cancer

AUA Guidelines: Salvage Therapy for Prostate Cancer

AUA Guidelines: Salvage Therapy for Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Yaw Nyame, MD, MS, MBA Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate ca...

14 Jan 27min

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
alska-oss
harrisons-dramatiska-historia
sektledare
nu-blir-det-historia
rss-viktmedicinpodden
johannes-hansen-podcast
roda-vita-rosen
allt-du-velat-veta
i-vantan-pa-katastrofen
rss-sjalsligt-avkladd
rss-max-tant-med-max-villman
rss-basta-livet
rss-om-vi-ska-vara-arliga
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-relationsrevolutionen
not-fanny-anymore
sa-in-i-sjalen